Long-term nocturnal calcium infusions can cure rickets and promote normal mineralization in hereditary resistance to 1,25-dihydroxyvitamin D (original) (raw)

Abstract

We report the beneficial effects of calcium infusions in a child with hereditary resistance to 1,25(OH)2D and alopecia. This patient after transient responsiveness to vitamin D derivatives became unresponsive to all therapy despite serum 1,25(OH)2D concentrations maintained at levels approximately 100-fold normal. A 7-mo trial with calcium infusions led to correction of biochemical abnormalities and healing of rickets. Bone biopsies (n = 3) showed a normal mineralization and the disappearance of the osteomalacia. Cultures of bone-derived cells demonstrated a lack of activation of 25-hydroxyvitamin D 24-hydroxylase and osteocalcin synthesis by 1,25(OH)2D3 (10(-9) and 10(-6) M). These results demonstrate that even in the absence of a normal 1,25(OH)2D3 receptor-effector system in bone cells, normal mineralization can be achieved in humans if adequate serum calcium and phosphorus concentrations are maintained; and calcium infusions may be an efficient alternative for the management of patients with this condition who are unresponsive to large doses of vitamin D derivatives.

1661

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen L. H. Calcium bioavailability and absorption: a review. Am J Clin Nutr. 1982 Apr;35(4):783–808. doi: 10.1093/ajcn/35.4.783. [DOI] [PubMed] [Google Scholar]
  2. Armbrecht H. J., Wasserman R. H. Enhancement of Ca++ uptake by lactose in the rat small intestine. J Nutr. 1976 Sep;106(9):1265–1271. doi: 10.1093/jn/106.9.1265. [DOI] [PubMed] [Google Scholar]
  3. Arnaud C. D., Tsao H. S., Littledike T. Radioimmunoassay of human parathyroid hormone in serum. J Clin Invest. 1971 Jan;50(1):21–34. doi: 10.1172/JCI106476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Balsan S., Garabedian M., Liberman U. A., Eil C., Bourdeau A., Guillozo H., Grimberg R., Le Deunff M. J., Lieberherr M., Guimbaud P. Rickets and alopecia with resistance to 1,25-dihydroxyvitamin D: two different clinical courses with two different cellular defects. J Clin Endocrinol Metab. 1983 Oct;57(4):803–811. doi: 10.1210/jcem-57-4-803. [DOI] [PubMed] [Google Scholar]
  5. Beer S., Tieder M., Kohelet D., Liberman O. A., Vure E., Bar-Joseph G., Gabizon D., Borochowitz Z. U., Varon M., Modai D. Vitamin D resistant rickets with alopecia: a form of end organ resistance to 1,25 dihydroxy vitamin D. Clin Endocrinol (Oxf) 1981 Apr;14(4):395–402. doi: 10.1111/j.1365-2265.1981.tb00626.x. [DOI] [PubMed] [Google Scholar]
  6. Brooks M. H., Bell N. H., Love L., Stern P. H., Orfei E., Queener S. F., Hamstra A. J., DeLuca H. F. Vitamin-D-dependent rickets type II. Resistance of target organs to 1,25-dihydroxyvitamin D. N Engl J Med. 1978 May 4;298(18):996–999. doi: 10.1056/NEJM197805042981804. [DOI] [PubMed] [Google Scholar]
  7. Brooks M. H., Stern P. H., Bell N. H. Vitamin D-dependent rickets type II. N Engl J Med. 1980 Apr 3;302(14):810–810. doi: 10.1056/nejm198004033021416. [DOI] [PubMed] [Google Scholar]
  8. Delmas P. D., Wahner H. W., Mann K. G., Riggs B. L. Assessment of bone turnover in postmenopausal osteoporosis by measurement of serum bone Gla-protein. J Lab Clin Med. 1983 Oct;102(4):470–476. [PubMed] [Google Scholar]
  9. EISENBERG E. EFFECTS OF SERUM CALCIUM LEVEL AND PARATHYROID EXTRACTS ON PHOSPHATE AND CALCIUM EXCRETION IN HYPOPARATHYROID PATIENTS. J Clin Invest. 1965 Jun;44:942–946. doi: 10.1172/JCI105211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Feldman D., Chen T., Cone C., Hirst M., Shani S., Benderli A., Hochberg Z. Vitamin D resistant rickets with alopecia: cultured skin fibroblasts exhibit defective cytoplasmic receptors and unresponsiveness to 1,25(OH)2D3. J Clin Endocrinol Metab. 1982 Nov;55(5):1020–1022. doi: 10.1210/jcem-55-5-1020. [DOI] [PubMed] [Google Scholar]
  11. Glorieux F. H., Marie P. J., Pettifor J. M., Delvin E. E. Bone response to phosphate salts, ergocalciferol, and calcitriol in hypophosphatemic vitamin D-resistant rickets. N Engl J Med. 1980 Oct 30;303(18):1023–1031. doi: 10.1056/NEJM198010303031802. [DOI] [PubMed] [Google Scholar]
  12. Hirst M. A., Hochman H. I., Feldman D. Vitamin D resistance and alopecia: a kindred with normal 1,25-dihydroxyvitamin D binding, but decreased receptor affinity for deoxyribonucleic acid. J Clin Endocrinol Metab. 1985 Mar;60(3):490–495. doi: 10.1210/jcem-60-3-490. [DOI] [PubMed] [Google Scholar]
  13. Hodson E. M., Evans R. A., Dunstan C. R., Hills E. E., Shaw P. F. Quantitative bone histology in children with chronic renal failure. Kidney Int. 1982 Jun;21(6):833–839. doi: 10.1038/ki.1982.107. [DOI] [PubMed] [Google Scholar]
  14. Holtrop M. E., Cox K. A., Clark M. B., Holick M. F., Anast C. S. 1,25-dihydroxycholecalciferol stimulates osteoclasts in rat bones in the absence of parathyroid hormone. Endocrinology. 1981 Jun;108(6):2293–2301. doi: 10.1210/endo-108-6-2293. [DOI] [PubMed] [Google Scholar]
  15. Knutson J. C., DeLuca H. F. 25-Hydroxyvitamin D3-24-hydroxylase. Subcellular location and properties. Biochemistry. 1974 Mar 26;13(7):1543–1548. doi: 10.1021/bi00704a034. [DOI] [PubMed] [Google Scholar]
  16. Kudoh T., Kumagai T., Uetsuji N., Tsugawa S., Oyanagi K., Chiba Y., Minami R., Nakao T. Vitamin D dependent rickets: decreased sensitivity to 1,25-dihydroxyvitamin D. Eur J Pediatr. 1981 Nov;137(3):307–311. doi: 10.1007/BF00443263. [DOI] [PubMed] [Google Scholar]
  17. Liberman U. A., Samuel R., Halabe A., Kauli R., Edelstein S., Weisman Y., Papapoulos S. E., Clemens T. L., Fraher L. J., O'Riordan J. L. End-organ resistance to 1,25-dihydroxycholecalciferol. Lancet. 1980 Mar 8;1(8167):504–506. doi: 10.1016/s0140-6736(80)92763-4. [DOI] [PubMed] [Google Scholar]
  18. Marx S. J., Liberman U. A., Eil C., Gamblin G. T., DeGrange D. A., Balsan S. Hereditary resistance to 1,25-dihydroxyvitamin D. Recent Prog Horm Res. 1984;40:589–620. doi: 10.1016/b978-0-12-571140-1.50019-0. [DOI] [PubMed] [Google Scholar]
  19. Marx S. J., Spiegel A. M., Brown E. M., Gardner D. G., Downs R. W., Jr, Attie M., Hamstra A. J., DeLuca H. F. A familial syndrome of decrease in sensitivity to 1,25-dihydroxyvitamin D. J Clin Endocrinol Metab. 1978 Dec;47(6):1303–1310. doi: 10.1210/jcem-47-6-1303. [DOI] [PubMed] [Google Scholar]
  20. Marx S. J., Swart E. G., Jr, Hamstra A. J., DeLuca H. F. Normal intrauterine development of the fetus of a woman receiving extraordinarily high doses of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1980 Nov;51(5):1138–1142. doi: 10.1210/jcem-51-5-1138. [DOI] [PubMed] [Google Scholar]
  21. Mathieu M., Bretaudiere J. P., Galteau M. M., Guidollet J., Lalegerie P., Bailly M., Buret P., Dorche C., Louisot P., Schiele F. Commission "enzymologie". Enzymologie courante en chimie clinique et recommandations pour la mesure des activités catalytiques dans le sérum à 30 degrés C. Ann Biol Clin (Paris) 1977;35(3):271–273. [PubMed] [Google Scholar]
  22. Murer H., Hildmann B. Transcellular transport of calcium and inorganic phosphate in the small intestinal epithelium. Am J Physiol. 1981 Jun;240(6):G409–G416. doi: 10.1152/ajpgi.1981.240.6.G409. [DOI] [PubMed] [Google Scholar]
  23. Norman A. W., Roth J., Orci L. The vitamin D endocrine system: steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev. 1982 Fall;3(4):331–366. doi: 10.1210/edrv-3-4-331. [DOI] [PubMed] [Google Scholar]
  24. Pike J. W., Dokoh S., Haussler M. R., Liberman U. A., Marx S. J., Eil C. Vitamin D3--resistant fibroblasts have immunoassayable 1,25-dihydroxyvitamin D3 receptors. Science. 1984 May 25;224(4651):879–881. doi: 10.1126/science.6326262. [DOI] [PubMed] [Google Scholar]
  25. Preece M. A., O'Riordan J. L., Lawson D. E., Kodicek E. A competitive protein-binding assay for 25-hydroxycholecalciferol and 25-hydroxyergocalciferol in serum. Clin Chim Acta. 1974 Jul 31;54(2):235–242. doi: 10.1016/0009-8981(74)90241-1. [DOI] [PubMed] [Google Scholar]
  26. Price P. A., Nishimoto S. K. Radioimmunoassay for the vitamin K-dependent protein of bone and its discovery in plasma. Proc Natl Acad Sci U S A. 1980 Apr;77(4):2234–2238. doi: 10.1073/pnas.77.4.2234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Richards G. M. Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal Biochem. 1974 Feb;57(2):369–376. doi: 10.1016/0003-2697(74)90091-8. [DOI] [PubMed] [Google Scholar]
  28. Rosen J. F., Fleischman A. R., Finberg L., Hamstra A., DeLuca H. F. Rickets with alopecia: an inborn error of vitamin D metabolism. J Pediatr. 1979 May;94(5):729–735. doi: 10.1016/s0022-3476(79)80139-0. [DOI] [PubMed] [Google Scholar]
  29. Schnoes H. K., DeLuca H. F. Recent progress in vitamin D metabolism and the chemistry of vitamin D metabolites. Fed Proc. 1980 Aug;39(10):2723–2729. [PubMed] [Google Scholar]
  30. Shepard R. M., Horst R. L., Hamstra A. J., DeLuca H. F. Determination of vitamin D and its metabolites in plasma from normal and anephric man. Biochem J. 1979 Jul 15;182(1):55–69. doi: 10.1042/bj1820055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Silver J., Landau H., Bab I., Shvil Y., Friedlaender M. M., Rubinger D., Popovtzer M. M. Vitamin D-dependent rickets types I and II. Diagnosis and response to therapy. Isr J Med Sci. 1985 Jan;21(1):53–56. [PubMed] [Google Scholar]
  32. Tsuchiya Y., Matsuo N., Cho H., Kumagai M., Yasaka A., Suda T., Orimo H., Shiraki M. An unusual form of vitamin D-dependent rickets in a child: alopecia and marked end-organ hyposensitivity to biologically active vitamin D. J Clin Endocrinol Metab. 1980 Oct;51(4):685–690. doi: 10.1210/jcem-51-4-685. [DOI] [PubMed] [Google Scholar]
  33. Underwood J. L., DeLuca H. F. Vitamin D is not directly necessary for bone growth and mineralization. Am J Physiol. 1984 Jun;246(6 Pt 1):E493–E498. doi: 10.1152/ajpendo.1984.246.6.E493. [DOI] [PubMed] [Google Scholar]
  34. Villanueva A. R., Kujawa M., Mathews C. H., Parfitt A. M. Identification of the mineralization front: comparison of a modified toluidine blue stain with tetracycline fluorescence. Metab Bone Dis Relat Res. 1983;5(1):41–45. doi: 10.1016/0221-8747(83)90049-8. [DOI] [PubMed] [Google Scholar]
  35. Weinstein R. S., Underwood J. L., Hutson M. S., DeLuca H. F. Bone histomorphometry in vitamin D-deficient rats infused with calcium and phosphorus. Am J Physiol. 1984 Jun;246(6 Pt 1):E499–E505. doi: 10.1152/ajpendo.1984.246.6.E499. [DOI] [PubMed] [Google Scholar]
  36. Witmer G., Margolis A., Fontaine O., Fritsch J., Lenoir G., Broyer M., Balsan S. Effects of 25-hydroxycholecalciferol on bone lesions of children with terminal renal failure. Kidney Int. 1976 Nov;10(5):395–408. doi: 10.1038/ki.1976.125. [DOI] [PubMed] [Google Scholar]
  37. Zerwekh J. E., Glass K., Jowsey J., Pak C. Y. An unique form of osteomalacia associated with end organ refractoriness to 1,25-dihydroxyvitamin D and apparent defective synthesis of 25-hydroxyvitamin D. J Clin Endocrinol Metab. 1979 Aug;49(2):171–175. doi: 10.1210/jcem-49-2-171. [DOI] [PubMed] [Google Scholar]